Clinical subphenotypes in septic patients with new-onset atrial fibrillation: validation and parsimonious classifier model development.
Source check: Source checked. Not independent scientific confirmation.
Finding: Consensus hierarchical clustering of 1,535 MIMIC-IV sepsis patients with new-onset atrial fibrillation identified three subphenotypes; a nine-classifier pipeline was evaluated in 257 MIMIC-III patients. Weighted observational treatment associations do not establish causal treatment effects.
Technology: Consensus hierarchical clustering derives three sepsis/NOAF subphenotypes, and nine classifiers build a concise phenotype classifier.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Consensus hierarchical clustering derives three sepsis/NOAF subphenotypes, and nine classifiers build a concise phenotype classifier.
- Test and result
- MIMIC-IV derivation (n=1,535) with MIMIC-III evaluation (n=257); retrospective treatment associations remain noncausal.
- Limitation / still unknown
- External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12911-026-03652-5 · https://pubmed.ncbi.nlm.nih.gov/42374411/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.